BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8784419)

  • 21. Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis.
    Miki T; Kori M; Mabuchi H; Tozawa R; Nishimoto T; Sugiyama Y; Teshima K; Yukimasa H
    J Med Chem; 2002 Sep; 45(20):4571-80. PubMed ID: 12238936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mannonerolidol, a new nerolidol mannoside from culture broth of Schizophyllum commune.
    Woo EE; Kim JY; Kim JS; Kwon SW; Lee IK; Yun BS
    J Antibiot (Tokyo); 2019 Mar; 72(3):178-180. PubMed ID: 30542161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kurasoins A and B, new protein farnesyltransferase inhibitors produced by Paecilomyces sp. FO-3684. I. Producing strain, fermentation, isolation, and biological activities.
    Uchida R; Shiomi K; Inokoshi J; Masuma R; Kawakubo T; Tanaka H; Iwai Y; Omura S
    J Antibiot (Tokyo); 1996 Sep; 49(9):932-4. PubMed ID: 8931728
    [No Abstract]   [Full Text] [Related]  

  • 24. The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors.
    Chan C; Andreotti D; Cox B; Dymock BW; Hutson JL; Keeling SE; McCarthy AD; Procopiou PA; Ross BC; Sareen M; Scicinski JJ; Sharratt PJ; Snowden MA; Watson NS
    J Med Chem; 1996 Jan; 39(1):207-16. PubMed ID: 8568810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RPR 101821, a new potent cholesterol-lowering agent: inhibition of squalene synthase and 7-dehydrocholesterol reductase.
    Amin D; Rutledge RZ; Needle SJ; Hele DJ; Neuenswander K; Bush RC; Bilder GE; Perrone MH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):233-40. PubMed ID: 8717165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo.
    Baxter A; Fitzgerald BJ; Hutson JL; McCarthy AD; Motteram JM; Ross BC; Sapra M; Snowden MA; Watson NS; Williams RJ
    J Biol Chem; 1992 Jun; 267(17):11705-8. PubMed ID: 1601846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenoxypropylamines: a new series of squalene synthase inhibitors.
    Brown GR; Butlin RJ; Chapman S; Eakin MA; Foubister AJ; Freeman S; Griffiths D; Harrison PJ; Johnson MC; Mallion KB
    J Med Chem; 1995 Oct; 38(21):4157-60. PubMed ID: 7473541
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological characterization in vitro of EP2306 and EP2302, potent inhibitors of squalene synthase and lipid biosynthesis.
    Tavridou A; Kaklamanis L; Megaritis G; Kourounakis AP; Papalois A; Roukounas D; Rekka EA; Kourounakis PN; Charalambous A; Manolopoulos VG
    Eur J Pharmacol; 2006 Mar; 535(1-3):34-42. PubMed ID: 16545796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthase.
    Amin D; Cornell SA; Perrone MH; Bilder GE
    Arzneimittelforschung; 1996 Aug; 46(8):759-62. PubMed ID: 9125274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of human smooth muscle cell proliferation in culture by farnesyl pyrophosphate analogues, inhibitors of in vitro protein: farnesyl transferase.
    Cohen LH; Pieterman E; van Leeuwen RE; Du J; Negre-Aminou P; Valentijn AR; Overhand M; van der Marel GA; van Boom JH
    Biochem Pharmacol; 1999 Feb; 57(4):365-73. PubMed ID: 9933024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pepticinnamins, new farnesyl-protein transferase inhibitors produced by an actinomycete. I. Producing strain, fermentation, isolation and biological activity.
    Omura S; Van der Pyl D; Inokoshi J; Takahashi Y; Takeshima H
    J Antibiot (Tokyo); 1993 Feb; 46(2):222-8. PubMed ID: 8468235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid-lowering (hetero)aromatic tetrahydro-1,4-oxazine derivatives with antioxidant and squalene synthase inhibitory activity.
    Kourounakis AP; Charitos C; Rekka EA; Kourounakis PN
    J Med Chem; 2008 Sep; 51(18):5861-5. PubMed ID: 18754614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. J-104,871, a novel farnesyltransferase inhibitor, blocks Ras farnesylation in vivo in a farnesyl pyrophosphate-competitive manner.
    Yonemoto M; Satoh T; Arakawa H; Suzuki-Takahashi I; Monden Y; Kodera T; Tanaka K; Aoyama T; Iwasawa Y; Kamei T; Nishimura S; Tomimoto K
    Mol Pharmacol; 1998 Jul; 54(1):1-7. PubMed ID: 9658183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syntheses of fused heterocyclic compounds and their inhibitory activities for squalene synthase.
    Miki T; Kori M; Fujishima A; Mabuchi H; Tozawa Ri; Nakamura M; Sugiyama Y; Yukimasa H
    Bioorg Med Chem; 2002 Feb; 10(2):385-400. PubMed ID: 11741787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis.
    Amin D; Cornell SA; Gustafson SK; Needle SJ; Ullrich JW; Bilder GE; Perrone MH
    J Lipid Res; 1992 Nov; 33(11):1657-63. PubMed ID: 1464749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and structural determination of squalene synthase inhibitor from Prunus mume fruit.
    Choi SW; Hur NY; Ahn SC; Kim DS; Lee JK; Kim DO; Park SK; Kim BY; Baik MY
    J Microbiol Biotechnol; 2007 Dec; 17(12):1970-5. PubMed ID: 18167444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational Discovery of Novel Squalene Synthase Inhibitors through Pharmacophore Modelling.
    Chokshi AB; Chhabria MT; Desai PR
    Curr Comput Aided Drug Des; 2018; 14(3):221-233. PubMed ID: 29732977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel 4,1-benzoxazepine derivatives with potent squalene synthase inhibitory activities.
    Miki T; Kori M; Mabuchi H; Banno H; Tozawa Ri; Nakamura M; Itokawa S; Sugiyama Y; Yukimasa H
    Bioorg Med Chem; 2002 Feb; 10(2):401-14. PubMed ID: 11741788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial activity of viridiofungins.
    Onishi JC; Milligan JA; Basilio A; Bergstrom J; Curotto J; Huang L; Meinz M; Nallin-Omstead M; Pelaez F; Rew D; Salvatore M; Thompson J; Vicente F; Kurtz MB
    J Antibiot (Tokyo); 1997 Apr; 50(4):334-8. PubMed ID: 9186560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accumulation of prenyl alcohols by terpenoid biosynthesis inhibitors in various microorganisms.
    Muramatsu M; Ohto C; Obata S; Sakuradani E; Shimizu S
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):589-95. PubMed ID: 18636253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.